Hiroko Inagaki

Ms. Hiroko Inagaki

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
HIHiroko Inagaki
Hiroko Inagaki
SASaito Akatsuki
Saito Akatsuki
CKChiho Kaneko
Chiho Kaneko
HShironobu sugiyama
hironobu sugiyama
TOTamaki Okabayashi
Tamaki Okabayashi
SFShouichi Fujimoto
Shouichi Fujimoto
More than 1 year has passed since social activities have been restricted due to the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). More recently, novel SARS-CoV-2 variants have been spreading around the world, and there is growing concern that they may have higher transmissibility and that the protective efficacy of vaccines may be weaker against them. Immediate measures are needed to reduce human exposure to the virus. In this study, the antiviral efficacy of deep-ultraviolet light-emitting diode (DUV-LED) irradiation (280 ± 5 nm, 3.75 mW/cm2) against three SARS-CoV-2 variants was evaluated. For the B.1.1.7, B.1.351, and P.1 variant strains, irradiation of the virus stocks for 1 s resulted in infectious titer reduction rates of 96.3%, 94.6%, and 91.9%, respectively, and with irradiation for 5 s, the rates increased to 99.9%, 99.9%, and 99.8%, respectively. We also tested the effect of pulsed DUV-LED irradiation (7.5 mW/cm2, duty rate: 50%, frequency: 1 kHz) under the same output conditions as for continuous irradiation and found that the antiviral efficacy of pulsed and continuous irradiation was the same. These findings suggest that by further developing and optimizing the DUV-LED device to increase its output, it may be possible to instantly inactivate SARS-CoV-2 with DUV-LED irradiation.

10 May 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
HIHiroko Inagaki
Hiroko Inagaki
SASaito Akatsuki
Saito Akatsuki
CKChiho Kaneko
Chiho Kaneko
HSHironobu Sugiyama
Hironobu Sugiyama
TOTamaki Okabayashi
Tamaki Okabayashi
SFShouichi Fujimoto
Shouichi Fujimoto
More than 1 year has passed since social activities have been restricted due to the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). More recently, novel SARS-CoV-2 variants have been spreading around the world, and there is growing concern of higher transmissibility of the variants and weaker protective efficacy of vaccine against the variants. Immediate measures are needed to reduce human exposure to the virus. In this study, the antiviral efficacy of deep-ultraviolet light-emitting diode (DUV-LED) irradiation (280 ± 5 nm, 3.75 mW/cm 2 ) against three SARS-CoV-2 variants was evaluated. For the B.1.1.7, B.1.351, and P.1 strains, the infectious titer reduction rates of 96.3%, 94.6%, and 91.9%, respectively, were already recognized with the irradiation of virus stocks for 1 s, and the rates increased to 99.9%, 99.9%, and 99.8%, respectively, with irradiation for 5 s. We also tested the effect of pulsed DUV-LED irradiation (7.5 mW/cm 2 , duty rate: 50%, frequency: 1 KHz) under the same output conditions as continuous irradiation, and found that the antiviral efficacy of pulsed and continuous irradiation was the same. These findings suggest that SARS-CoV-2 may be instantly inactivated by DUV-LED irradiation if the DUV-LED device is further developed and optimized to increase its output.

2 November 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
HIHiroko Inagaki
Hiroko Inagaki
SASaito Akatsuki
Saito Akatsuki
PSPutu Eka Sudaryatma
Putu Eka Sudaryatma
HSHironobu Sugiyama
Hironobu Sugiyama
TOTamaki Okabayashi
Tamaki Okabayashi
SFShouichi Fujimoto
Shouichi Fujimoto
Although ozone water is one of the promising candidates for hand hygiene to prevent fomite infection, the detailed effects of ozone water on SARS-CoV-2 have not been clarified. We evaluated the inactivating effect of ozone water against SARS-CoV-2 by its concentration and exposure time. The reduction rates of virus titer after 5 sec treatment with ozone concentrations of 1, 4, 7, and 10 mg/L were 81.4%, 93.2%, 96.6%, and 96.6%, respectively. No further decrease in virus titer was observed by the extended exposure time over 5 sec. High-concentration ozone water was considered to be effective in promptly inactivating SARS-CoV-2 virus.

13 August 2026 in Kidney360
Verified
Journal Article
Open access
KFKenta Fujimoto
Kenta Fujimoto
MKMasao Kikuchi
Masao Kikuchi
AGAtsushi Goan
Atsushi Goan
SKSayaka Kuroda
Sayaka Kuroda
SOShoko Ochiai
Shoko Ochiai
SFShouichi Fujimoto
Shouichi Fujimoto
Background: Complement activation plays a central role in the pathogenesis of ANCA-associated vasculitis (AAV). However, the clinical implications of urinary complement fragments remain unclear. We investigated whether urinary complement fragments reflect the severity of renal injury and whether they are associated with renal outcomes in patients with AAV . Methods: We retrospectively analyzed 57 patients with AAV and renal involvement. Urinary complement C3a, C5a, and C5b-9 levels were measured at diagnosis or relapse and normalized to urinary creatinine (U-C3a/Cr, U-C5a/Cr, and U-C5b-9/Cr). The primary outcome was a composite of ESKD requiring chronic dialysis or all-cause mortality. Secondary analyses evaluated longitudinal changes in eGFR and myeloperoxidase-ANCA titers, and associations with renal histopathological findings at diagnosis. Results: Over a median follow-up of 21.5 months, 14 patients reached the primary outcome. Event-free survival was significantly lower in the high U-C3a/Cr and U-C5a/Cr groups than in the corresponding low groups. High baseline U-C3a/Cr and U-C5a/Cr were associated with 3.86-fold and 3.73-fold higher unadjusted risks of the primary composite outcome, respectively. However, the U-C5a/Cr ratio showed a broader association with renal disease severity. Higher U-C5a/Cr ratios were associated with less improvement in eGFR during follow-up and with several histopathological abnormalities, including a higher proportion of cellular crescents, lower proportion of normal glomeruli, and more severe tubulointerstitial lesions. Exploratory analyses combining urinary complement markers with baseline eGFR demonstrated progressive separation of renal risk categories, particularly for the U-C5a/Cr–eGFR classification. Conclusions: U-C5a/Cr was associated with renal outcomes, impaired renal functional recovery, and histopathological severity of AAV. Although U-C3a/Cr and U-C5a/Cr showed prognostic associations, U-C5a/Cr reflected intrarenal disease severity more consistently. Exploratory urinary complement–eGFR classifications may provide complementary noninvasive information for renal risk stratification in AAV. Further prospective multicenter studies are required to validate these findings.